Literature DB >> 18665036

Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.

Hua-chuan Zheng1, Hiroshi Saito, Shinji Masuda, Zhi-gang Wang, Yasuo Takano.   

Abstract

Maspin, a serine protease inhibitor related to the serpin family, can inhibit invasion and metastasis of malignancies although direct evidence of the clinicopathologic significance of cytoplasmic relative to nuclear expression is limited. Here, maspin expression was examined on tissue microarrays containing lung carcinoma (n=155) and adjacent noncancerous tissue (n=20) and also 4 lung carcinoma cell lines (LC-1/Sq, LC-IF, PC-14, and AoI) by immunohistochemistry. Maspin expression was compared with clinicopathologic parameters of the tumors. Maspin expression showed positive nuclear staining in basal cells, LC-IF, and PC-14 cell lines, and also cytoplasmic immunoreactivity in secretory and ciliated cells, LC-1/Sq cell line. Cytoplasmic staining was the lowest in adenocarcinoma (AD) and the highest in squamous cell carcinoma as compared with other types of lung carcinoma (P<0.05), and positively correlated with expression of p53 and caspase-3 (P<0.05). The cytoplasmic one showed stronger immunoreactivity in male carcinoma patients than female ones (P<0.05). The nuclear maspin expression gradually increased through squamous cell carcinoma, AD, large cell carcinoma to small cell carcinoma (P<0.05) and was also positively associated with the levels of vascular epithelial growth factor and extracellular matrix metalloproteinase inducer expression (P<0.05). Kaplan-Meier analysis indicated that the cytoplasmic or nuclear maspin expression was not a good prognostic marker for lung carcinomas overall (P>0.05), but the cytoplasmic pattern pointed to good survival for AD cases (P<0.05). It was concluded that the cytoplasmic and nuclear expression patterns of maspin are involved in the cellular differentiation of normal lung tissue and the histogenesis of different lung carcinomas. The cytoplasmic maspin may play an important role in lung carcinomas by regulating apoptosis and thus is a favorable prognostic marker for AD patients, whereas the nuclear location may be linked to promotion of angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18665036     DOI: 10.1097/PAI.0b013e3181640bb1

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  10 in total

1.  HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione S-transferase pi in prostate carcinoma cells.

Authors:  Xiaohua Li; Alexander Kaplun; Fulvio Lonardo; Elisabeth Heath; Fazlul H Sarkar; Jonathan Irish; Wael Sakr; Shijie Sheng
Journal:  Mol Cancer Res       Date:  2011-05-26       Impact factor: 5.852

2.  Maspin, VEGF and p53 expression in small biopsies of primary advanced lung cancer and relationship with clinicopathologic parameters.

Authors:  Ahmet Bircan; Sema Bircan; Nilgun Kapucuoglu; Necla Songur; Onder Ozturk; Ahmet Akkaya
Journal:  Pathol Oncol Res       Date:  2010-03-28       Impact factor: 3.201

Review 3.  RANK-mediated signaling network and cancer metastasis.

Authors:  Gina Chia-Yi Chu; Leland W K Chung
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

4.  Decreased maspin combined with elevated vascular endothelial growth factor C is associated with poor prognosis in non-small cell lung cancer.

Authors:  Xing Wang; Yang Wang; Shaolei Li; Bin Dong; Qingfeng Zheng; Shi Yan; Yuanyuan Ma; Jianzhi Zhang; Jian Fang; Nan Wu; Huijuan Wu; Yue Yang
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

5.  High frequency of coexpression of maspin with p63 and p53 in squamous cell carcinoma but not in adenocarcinoma of the lung.

Authors:  Bonnie Choy; Jennifer J Findeis-Hosey; Faqian Li; Loralee A McMahon; Qi Yang; Haodong Xu
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

6.  Increased IKKα expression in the basal layer of the epidermis of transgenic mice enhances the malignant potential of skin tumors.

Authors:  Josefa P Alameda; Rodolfo Moreno-Maldonado; M Jesús Fernández-Aceñero; Manuel Navarro; Angustias Page; José L Jorcano; Ana Bravo; Ángel Ramírez; M Llanos Casanova
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

7.  Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer.

Authors:  N Snoeren; B L Emmink; M J G Koerkamp; S R van Hooff; J A C M Goos; W J van Houdt; M de Wit; A M Prins; S R Piersma; T V Pham; E J Belt; H Bril; H B Stockmann; G A Meijer; R van Hillegersberg; F C Holstege; C R Jimenez; R J A Fijneman; O W Kranenburg; I H M Borel Rinkes
Journal:  Br J Cancer       Date:  2013-09-03       Impact factor: 7.640

8.  Aberrant Maspin mRNA Expression is Associated with Clinical Outcome in Patients with Pulmonary Adenocarcinoma.

Authors:  Mingjie Lu; Jun Li; Zebo Huang; Yiping Du; Shidai Jin; Jian Wang
Journal:  Med Sci Monit       Date:  2016-01-13

9.  The roles of maspin expression in gastric cancer: a meta- and bioinformatics analysis.

Authors:  Hua-Chuan Zheng; Bao-Cheng Gong
Journal:  Oncotarget       Date:  2017-08-11

10.  The roles of MASPIN expression and subcellular localization in non-small cell lung cancer.

Authors:  Xiao-Fei Wang; Bo Liang; Da-Xiong Zeng; Wei Lei; Cheng Chen; Yan-Bin Chen; Jian-An Huang; Ning Gu; Ye-Han Zhu
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.